CAT and fatty liver disease: Hepatic steatosis was accompanied with an elevation in the hepatic biomarkers of redox status evidenced by a drop in the hepatic catalase and GST levels significantly by about 75% and 57%, respectively, accompanied by an increase in the hepatic MPO level by 3.4 folds.